HomeCompareAIKI vs KO

AIKI vs KO: Dividend Comparison 2026

AIKI yields 56.18% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AIKI wins by $505.2K in total portfolio value
10 years
AIKI
AIKI
● Live price
56.18%
Share price
$3.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$539.3K
Annual income
$119,796.88
Full AIKI calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — AIKI vs KO

📍 AIKI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAIKIKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AIKI + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AIKI pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIKI
Annual income on $10K today (after 15% tax)
$4,775.28/yr
After 10yr DRIP, annual income (after tax)
$101,827.35/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, AIKI beats the other by $98,169.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIKI + KO for your $10,000?

AIKI: 50%KO: 50%
100% KO50/50100% AIKI
Portfolio after 10yr
$286.7K
Annual income
$62,050.33/yr
Blended yield
21.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

AIKI
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.9
Piotroski
6/9
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIKI buys
0
KO buys
0
No recent congressional trades found for AIKI or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAIKIKO
Forward yield56.18%2.70%
Annual dividend / share$2.00$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$539.3K$34.1K
Annual income after 10y$119,796.88$4,303.79
Total dividends collected$441.4K$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: AIKI vs KO ($10,000, DRIP)

YearAIKI PortfolioAIKI Income/yrKO PortfolioKO Income/yrGap
1← crossover$16,318$5,617.98$10,846$335.73+$5.5KAIKI
2$26,028$8,567.67$11,829$430.64+$14.2KAIKI
3$40,622$12,771.79$12,988$555.50+$27.6KAIKI
4$62,094$18,628.85$14,372$721.34+$47.7KAIKI
5$93,054$26,613.05$16,049$944.01+$77.0KAIKI
6$136,840$37,273.01$18,114$1,246.74+$118.7KAIKI
7$197,645$51,226.14$20,702$1,664.24+$176.9KAIKI
8$280,629$69,148.09$24,008$2,249.48+$256.6KAIKI
9$392,030$91,757.54$28,317$3,085.19+$363.7KAIKI
10$539,269$119,796.88$34,065$4,303.79+$505.2KAIKI

AIKI vs KO: Complete Analysis 2026

AIKIStock

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Full AIKI Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this AIKI vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIKI vs SCHDAIKI vs JEPIAIKI vs OAIKI vs MAINAIKI vs PEPAIKI vs PGAIKI vs JNJAIKI vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.